✦ LIBER ✦

Discovery of imatinib-responsiveFIP1L1-PDGFRAmutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia

✍ Scribed by Shah, Shilpan; Loghavi, Sanam; Garcia-Manero, Guillermo; Khoury, Joseph D

Book ID: 125403606
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 294 KB
Volume: 7
Category: Article
ISSN: 1756-8722
DOI: 10.1186/1756-8722-7-26

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute myeloid leukemia developing during

Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities

✍ Attaphol Pawarode; Sheila N.J. Sait; Alain Nganga; Lionel J. Coignet; Maurice Ba 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 171 KB

The BCR/ABL tyrosine kinase inhibitor imatinib mesylate produces a high rate of cytogenetic responses in patients with Philadelphia (Ph)-positive chronic myeloid leukemia (CML), but secondary clonal chromosome abnormalities may develop in Ph-negative cells, and acute myeloid leukemia (AML) has been

Development of acute myeloid leukemia as

Development of acute myeloid leukemia associated with Ph-negative clone with inv(3)(q21q26) during imatinib therapy for chronic myeloid leukemia

✍ Pavel Dvorak; Martina Hruba; Ivan Subrt 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 288 KB

A novel variant form of MLL-ELL fusion t

A novel variant form of MLL-ELL fusion transcript with t(11;19)(q23;p13.1) in chronic myelomonocytic leukemia transforming to acute myeloid leukemia

✍ Kazuhiko Kakihana; Fumito Kubo; Shihoko Wakabayashi; Tetsuya Kurosu; Tohru Miki; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Fas ligand is highly expressed in acute

Fas ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis

✍ Jason D. Lickliter; Robert A. Kratzke; Phuong L. Nguyen; Gloria A. Niehans; Jeff 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 849 KB

Quantitative molecular monitoring of BCR

Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment

✍ Sara Galimberti; Giulia Cervetti; Francesca Guerrini; Rossana Testi; Simone Paci 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 293 KB